SMAD3 and melanoma: The critical role of NK cell immunity in Smad3-dependent tumour microenvironment was further demonstrated by depleting NK cells from tumour-bearing Smad3−/− mice with a neutralizing anti-NK1.1 antibody to restore the aggressive progression of melanoma.